{"nct_id":"NCT02193113","title":"A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME","status":"COMPLETED","status_verified_date":"2017-03","start_date":"2014-07-18","start_date_type":"ACTUAL","primary_completion_date":"2015-06-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-06-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["KALV"]}